ARCHIVES

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

This article is from The Cancer Letter archive.

Vol. 16 No. 10 | March 9, 1990

Download PDF Visit The Full Archive

Related Articles

Senate Gives NIH Director Authority To Permit Research By Unconventional MDs

September 25, 1992

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003